Critics say FDA's off-label guidance allows marketing disguised as science.
Mitka
Mike
M
D016265:Conflict of Interest; D030881:Disclosure; D017277:Drug Approval; D004345:Drug Industry; D017408:Guidelines as Topic; D040541:Marketing / Q000331:legislation & jurisprudence / Q000592:standards*; D011643:Publishing / Q000331:legislation & jurisprudence / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration